|
Age at clinic (years)
|
24.5 (21.0-35.8)
|
39.0 (23.0-63.8)*
|
|
Age at diagnosis (years)
|
18.0 (11.0-24.5)
|
17.0 (11.3–51.8)
|
|
Diabetes duration (years)
|
9.0 (2.0–17.0)
|
9.5 (5.8–18.8)
|
|
Female [n (%)]
|
16 (44)
|
6 (43)
|
|
Body weight (kg)
|
63.4 (60.3–73.1)
|
67.3 (59.6–75.0)
|
|
BMI (kg/m2)
|
22.6 (20.1–23.5)
|
23.2 (22.0-24.6)
|
|
HbA1c (mmol/mol)
|
65.0 (55.0-74.8)
|
88.5 (70.8-105.3)*
|
|
Total Insulin dose (units)
|
42.0 (30.6–50.3)
|
41.5 (31.5–58.3)
|
|
Insulin dose (unit/kg/day)
|
0.65 (0.47–0.77)
|
0.68 (0.50–0.76)
|
|
Total Cholesterol (mmol/L)
|
3.8 (3.4–4.9)
|
4.3 (3.7–5.4)
|
|
Triglyceride (mmol/L)
|
0.9 (0.7–1.3)
|
1.3 (0.8–1.6)
|
|
HDL Cholesterol (mmol/L)
|
1.6 (1.3–1.9)
|
1.6 (1.4-2.0)
|
|
LDL Cholesterol (mmol/L)
|
2.0 (1.6–2.5)
|
2.2 (1.9-3.0)
|
|
Hypertension, [n (%)]
|
0 (0)
|
4 (29)*
|
|
Statins [n (%)]
|
7 (19)
|
4 (29)
|
|
ACEI/ARB [n (%)]
|
2 (6)
|
2 (14)
|
|
Metformin [n (%)]
|
4 (11)
|
3 (21)
|
|
Microalbuminuria, [n (%)]
|
0 (0)
|
5 (36)*
|
|
eGDR
|
9.0 (8.6–10.0)
|
7.1 (5.6–7.4)*
|
